Synthesis and pharmacological evaluation of a new homologous series of (+/-)-p-fluoro-phenyl alcohol amide anticonvulsants. 1998

G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
Departamento de Bioquímica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, México D. F., México.

The anticonvulsant activity of a homologous series of (+/-)-p-fluoro-phenyl alcohol amides is described. The compounds (+/-)-2-hydroxy-2-(4'-fluorophenyl)butyramide (2), (+/-)-3-hydroxy-3-(4'-fluorophenyl)pentanamide (4) and (+/-)-4-hydroxy-4-(4'-fluorophenyl)hexanamide (6) were prepared and tested. Compounds 2, 4 and 6 exhibited a similar significant activity in seizures provoked by pentylenetetrazol. Incorporation of fluorine in the para position of the phenyl ring, increased both their potency at the time of the peak drug effect and the duration of their anticonvulsant activity.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D010421 Pentanoic Acids Straight-chain CARBOXYLIC ACIDS with the general formula C5H10O2. Acids, Pentanoic
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D002087 Butyrates Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure. Butyrate,n-Butyrate,Butanoic Acids,Butyric Acids,Acids, Butanoic,Acids, Butyric,n Butyrate
D002208 Caproates Derivatives of caproic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a carboxy terminated six carbon aliphatic structure. Hexanoates,Caproic Acid Derivatives,Caproic Acids,Hexanoic Acid Derivatives,Hexanoic Acids,Acid Derivatives, Caproic,Acid Derivatives, Hexanoic,Acids, Caproic,Acids, Hexanoic,Derivatives, Caproic Acid,Derivatives, Hexanoic Acid
D003292 Convulsants Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. Convulsant,Convulsant Effect,Convulsant Effects,Effect, Convulsant,Effects, Convulsant
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
January 2004, Arzneimittel-Forschung,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
July 1999, Bioorganic & medicinal chemistry letters,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
May 2013, Indian journal of pharmaceutical sciences,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
November 2008, European journal of medicinal chemistry,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
October 2001, Bioorganic & medicinal chemistry,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
September 1953, British journal of pharmacology and chemotherapy,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
April 2003, Bioorganic & medicinal chemistry,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
October 1990, Journal of medicinal chemistry,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
February 1968, Bollettino della Societa italiana di biologia sperimentale,
G Carvajal-Sandoval, and E Juárez-Carvajal, and C Cruz-Peinado, and S E Meza-Toledo
February 2017, Bioorganic chemistry,
Copied contents to your clipboard!